Literature DB >> 23685992

[Topical pain therapy in oral mucositis: a systematic review].

H Bornemann-Cimenti1, S K Kobald, I S Szilagyi, A Sandner-Kiesling.   

Abstract

BACKGROUND: The pain provoked by mucositis is often described as the most excruciating symptom of cancer treatment. It often causes reduced ingestion, malnutrition, and sometimes postponement or withdrawal of the therapy. For health care providers, adequate pain treatment is a major challenge. The aim of this article is to present an overview of studies on the topical treatment of mucositis pain.
METHODS: A systematic search was performed in PubMed with the keywords "mucositis" "pain" and "topical" or "local". In addition, reference lists and relevant websites were scanned for appropriate literature.
RESULTS: A total of 47 articles were included. There is only scarce evidence for the topical treatment of mucositis pain. The most convincing studies tested opioids, corticoids and benzydamine. For the other substances, too few studies were performed, the results were contradictory, or the study quality was low.
CONCLUSION: Based on the information gathered in this systematic search of the literature, topical treatment of mucositis pain today is based on empiricism and not on scientific evidence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685992     DOI: 10.1007/s00482-013-1318-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  70 in total

1.  Use of sublingual methadone for treating pain of chemotherapy-induced oral mucositis.

Authors:  Anita Gupta; Benjamin Duckles; James Giordano
Journal:  J Opioid Manag       Date:  2010 Jan-Feb

2.  Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer.

Authors:  W Wagner; M Alfrink; U Haus; J Matt
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

3.  Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy.

Authors:  J B Epstein; E L Truelove; H Oien; C Allison; N D Le; M S Epstein
Journal:  Oral Oncol       Date:  2001-12       Impact factor: 5.337

4.  Oral doxepin rinse: the analgesic effect and duration of pain reduction in patients with oral mucositis due to cancer therapy.

Authors:  Joel B Epstein; Joshua D Epstein; Matthew S Epstein; Hal Oien; Edmond L Truelove
Journal:  Anesth Analg       Date:  2006-08       Impact factor: 5.108

5.  A controlled trial of a dissolving oral patch concerning glycyrrhiza (licorice) herbal extract for the treatment of aphthous ulcers.

Authors:  Michael D Martin; Jefrey Sherman; Peter van der Ven; Jeffrey Burgess
Journal:  Gen Dent       Date:  2008 Mar-Apr

6.  Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx.

Authors:  J H Kim; F C Chu; V Lakshmi; R Houde
Journal:  Am J Clin Oncol       Date:  1986-04       Impact factor: 2.339

Review 7.  Fentanyl for the treatment of tumor-related breakthrough pain.

Authors:  Helmar Bornemann-Cimenti; Mischa Wejbora; Istvan S Szilagyi; Andreas Sandner-Kiesling
Journal:  Dtsch Arztebl Int       Date:  2013-04-19       Impact factor: 5.594

8.  Topical minocycline for managing symptoms of recurrent aphthous stomatitis.

Authors:  Meir Gorsky; Joel Epstein; Alon Raviv; Roni Yaniv; Edmond Truelove
Journal:  Spec Care Dentist       Date:  2008 Jan-Feb

9.  The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation.

Authors:  Samuel Vokurka; Jana Skardova; Renata Hruskova; Klara Kabatova-Maxova; Tomas Svoboda; Eva Bystricka; Katerina Steinerova; Vladimir Koza
Journal:  Med Sci Monit       Date:  2011-10

10.  Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.

Authors:  Claire Barber; Roy Powell; Annie Ellis; Julie Hewett
Journal:  Support Care Cancer       Date:  2006-11-28       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.